NDA Advisory Board

The NDA Advisory Board brings together some of the most prominent experts in regulatory affairs, pharmacovigilance and HTA. All are ex-regulators or senior industry leaders, renown for the contribution they have made to drug development throughout their careers.

NDA Advisory Board Experts

Albert L. Kraus

Advisory Board Member

Björn Carlsson

Director of the Advisory Board

Chantal Van Gils

VP Evidence & Value

Frits Lekkerkerker

Advisory Board Member

Jan Sjöberg

Medical Advisor & Advisory Board Member

Jenny Sims

Advisory Board Member

Julia Dunne

Advisory Board Member

Karl-Heinz Huemer

Advisory Board Member

Mads Hansen

Advisory Board Member

Margaret Mitrane

Advisory Board Member

Margarida Menezes Ferreira

Advisory Board Member

Marianne Scheel Fjording

Advisory Board Member

Mark Goldberger

Advisory Board Member

Mary Teeling

Advisory Board Member

Mel Walker

Advisory Board Member

Patrick Salmon

Advisory Board Member

Paula Salmikangas

Advisory Board Director

Pieter Neels

Advisory Board Director

Sigrid Klaar

Medical Advisor & Advisory Board Member

Simon Day

Advisory Board Member

Thomas Lönngren

Strategic Advisor

Vidar Wendel-Hansen

Advisory Board Member

Yngve Mikkelsen

Advisory Board Member

Beatriz Silva Lima

Advisory Board Member

Carole Longson

Advisory Board Member

Matthias Graf von der Schulenburg

Advisory Board Member

Lars J. Petersen

Advisory Board Member

Peter Kolominsky-Rabas

Advisory Board Member

LET’S TALK

You don't have to go it alone!

Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs